Application of the International System for Reporting Serous Fluid Cytopathology: An Experience at a Tertiary Care Centre in India

Shashikant Singh, Prajwala Gupta, Anukrishnaa Kannappan
{"title":"Application of the International System for Reporting Serous Fluid Cytopathology: An Experience at a Tertiary Care Centre in India","authors":"Shashikant Singh, Prajwala Gupta, Anukrishnaa Kannappan","doi":"10.4103/jme.jme_23_23","DOIUrl":null,"url":null,"abstract":"\n \n \n The cytological analysis of body fluids is the preliminary investigation performed for the diagnostic evaluation of body fluids, helping the physician make the diagnosis and plan proper treatment. The International System for Reporting Serous Fluid Cytology (ISFRSFC) was created using best international practises, current literature and expert consensus to make a uniform reporting system for serous fluids.\n \n \n \n The present study was conducted with the aim of recategorising the effusion fluids as per the guidelines prescribed by ISRFRC, knowing the distribution of cases into various categories and assessing their feasibility in day-to-day reporting.\n \n \n \n This study was performed on serous fluids (ascitic, pleural, peritoneal and pericardial) received over a period of 5 years, from January 2017 to April 2022, in the cytology unit of the Department of Pathology, ABVIMS, Dr. Ram Manohar Lohia Hospital, New Delhi. Wherever possible, clinicoradiological and histopathological data were obtained and correlated with cytological findings. Serous fluids were categorised into reporting formats as prescribed by ISRFRC and its feasibility was assessed in day-to-day reporting.\n \n \n \n A total of 1115 cases of serous effusion fluid were examined. The male-to-female ratio was 1:1.12. Pleural fluid constituted the majority of the sample (436, 39.10%). Overall, 56 (5.02%) cases were non-diagnostic (ND), 1013 (90.85%) cases were negative for malignancy, 8 (0.72%) were atypia of undetermined significance, 11 (0.99%) were suspicious of malignancy and 27 (2.42%) were malignant (MAL).\n \n \n \n The current study emphasises the significance of cytological analysis of serous fluid as a comprehensive diagnostic investigation that also aids in determining the cause and monitoring the disease process. With the introduction of ISFRSFC, serous fluid reporting is now uniform and more comprehensive, both for cytopathologists and clinicians.\n","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"1 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Evidence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jme.jme_23_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The cytological analysis of body fluids is the preliminary investigation performed for the diagnostic evaluation of body fluids, helping the physician make the diagnosis and plan proper treatment. The International System for Reporting Serous Fluid Cytology (ISFRSFC) was created using best international practises, current literature and expert consensus to make a uniform reporting system for serous fluids. The present study was conducted with the aim of recategorising the effusion fluids as per the guidelines prescribed by ISRFRC, knowing the distribution of cases into various categories and assessing their feasibility in day-to-day reporting. This study was performed on serous fluids (ascitic, pleural, peritoneal and pericardial) received over a period of 5 years, from January 2017 to April 2022, in the cytology unit of the Department of Pathology, ABVIMS, Dr. Ram Manohar Lohia Hospital, New Delhi. Wherever possible, clinicoradiological and histopathological data were obtained and correlated with cytological findings. Serous fluids were categorised into reporting formats as prescribed by ISRFRC and its feasibility was assessed in day-to-day reporting. A total of 1115 cases of serous effusion fluid were examined. The male-to-female ratio was 1:1.12. Pleural fluid constituted the majority of the sample (436, 39.10%). Overall, 56 (5.02%) cases were non-diagnostic (ND), 1013 (90.85%) cases were negative for malignancy, 8 (0.72%) were atypia of undetermined significance, 11 (0.99%) were suspicious of malignancy and 27 (2.42%) were malignant (MAL). The current study emphasises the significance of cytological analysis of serous fluid as a comprehensive diagnostic investigation that also aids in determining the cause and monitoring the disease process. With the introduction of ISFRSFC, serous fluid reporting is now uniform and more comprehensive, both for cytopathologists and clinicians.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血清液细胞病理学国际报告系统的应用:印度一家三级医疗中心的经验
体液细胞学分析是对体液进行诊断评估的初步调查,有助于医生做出诊断并制定适当的治疗计划。国际浆液细胞学报告系统(ISFRSFC)是根据最佳国际惯例、当前文献和专家共识建立的,旨在为浆液建立统一的报告系统。 本研究旨在根据 ISFRSFC 规定的准则对流出液进行重新分类,了解不同类别病例的分布情况,并评估其在日常报告中的可行性。 这项研究的对象是新德里拉姆-马诺哈尔-洛希亚博士医院(ABVIMS)病理科细胞学室在 2017 年 1 月至 2022 年 4 月的 5 年间接收的血清液(腹水、胸水、腹膜和心包积液)。在可能的情况下,我们获取了临床放射学和组织病理学数据,并将其与细胞学检查结果进行了关联。根据 ISRFRC 规定的报告格式对血清液进行分类,并评估其在日常报告中的可行性。 共检查了 1115 例浆液性渗出液病例。男女比例为 1:1.12。胸腔积液占样本的大部分(436 例,39.10%)。总体而言,56 例(5.02%)为非诊断性病例(ND),1013 例(90.85%)为恶性肿瘤阴性病例,8 例(0.72%)为意义不明的不典型病例,11 例(0.99%)为恶性肿瘤可疑病例,27 例(2.42%)为恶性肿瘤(MAL)。 本研究强调了浆液细胞学分析作为一项综合诊断检查的重要性,它还有助于确定病因和监测疾病进程。随着ISFRSFC的引入,对于细胞病理学家和临床医生来说,浆液报告现已统一且更加全面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Ghost Gall Bladder A Narrative Review on Dengue and COVID-19 Co-infection: A Deadly Duo National Medical Commission’s Generic Drug Policy: A Boon or a Bane for RMPs and Public Health? RESUSC-O: A Community Cardiopulmonary–Cerebral Resuscitation Provider App Impact of Foundation Course on First MBBS Students and Their Level of Satisfaction – A Programme Evaluation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1